| TRADING CENTER |
| Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Confer... - PR Newswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 56.85 | 0.30 / 0.53% | 10.87 |
| GILD | Gilead Sciences Inc | 46.59 | 0.33 / 0.71% | 17.99 |
| CELG | Celgene Corporation | 55.97 | -0.56 / -0.99% | 67.43 |
| 2008 Revenue: | $4.0 M | Headquarters: San Diego, CA |
| Employees: | 125 | CEO: Dr. Kevin C. Gorman, Ph.D. |
| Net Income: | $-88,613,000.0 | Industry: Biotechnology |
| Market Cap: | $85.5 M | Website: www.neurocrine.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| NBIX | 2.16 | -0.02 / -0.92% | 2.18 | 2.30 | 2.11 | Profile Chart News |